Literature DB >> 25270121

Understanding process-of-care delays in surgical treatment of breast cancer at a comprehensive cancer center.

Mehra Golshan1, Katya Losk, Sarah Kadish, Nancy U Lin, Judith Hirshfield-Bartek, Linda Cutone, Yasuaki Sagara, Fatih Aydogan, Kristen Camuso, Saul N Weingart, Craig Bunnell.   

Abstract

Few studies have examined care processes within providers' and institutions' control that expedite or delay care. The authors investigated the timeliness of breast cancer care at a comprehensive cancer center, focusing on factors influencing the time from initial consultation to first definitive surgery (FDS). The care of 1,461 women with breast cancer who underwent surgery at Dana-Farber/Brigham and Women's Cancer Center from 2011 to 2013 was studied. The interval between consultation and FDS was calculated to identify variation in timeliness of care based on procedure, provider, and patients' sociodemographic characteristics. Targets of 14 days for lumpectomy and mastectomy and 28 days from mastectomy with immediate reconstruction were set and used to define delay. Mean days between consultation and FDS was 21.6 (range 1-175, sd 15.8) for lumpectomy, 36.7 (5-230, 29.1) for mastectomy, and 37.5 (7-111, 16) for mastectomy with reconstruction. Patients under 40 were less likely to be delayed (OR = 0.56, 95 % CI = 0.33-0.94, p = 0.03). Patients undergoing mastectomy alone (OR = 2.64, 95 % CI = 1.80-3.89, p < 0.0001) and mastectomy with immediate reconstruction (OR = 1.34 95 % CI = 1.00-1.79, p = 0.05) were more likely to be delayed when compared to lumpectomy. Substantial variation in surgical timeliness was identified. This study provides insight into targets for improvement including better coordination with plastic surgery and streamlining pre-operative testing. Cancer centers may consider investing in efforts to measure and improve the timeliness of cancer care.

Entities:  

Mesh:

Year:  2014        PMID: 25270121     DOI: 10.1007/s10549-014-3124-2

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  6 in total

1.  The Influence of Radiology Image Consultation in the Surgical Management of Breast Cancer Patients.

Authors:  Melissa Anne Mallory; Katya Losk; Nancy U Lin; Yasuaki Sagara; Robyn L Birdwell; Linda Cutone; Kristen Camuso; Craig Bunnell; Fatih Aydogan; Mehra Golshan
Journal:  Ann Surg Oncol       Date:  2015-07-23       Impact factor: 5.344

2.  Is Medicaid Expansion Narrowing Gaps in Surgical Disparities for Low-Income Breast Cancer Patients?

Authors:  Samilia Obeng-Gyasi; Johnie Rose; Weichuan Dong; Uriel Kim; Siran Koroukian
Journal:  Ann Surg Oncol       Date:  2021-11-27       Impact factor: 4.339

3.  Rural-Urban Differences in Breast Cancer Surgical Delays in Medicare Beneficiaries.

Authors:  Ronnie J Zipkin; Andrew Schaefer; Changzhen Wang; Andrew P Loehrer; Nirav S Kapadia; Gabriel A Brooks; Tracy Onega; Fahui Wang; Alistair J O'Malley; Erika L Moen
Journal:  Ann Surg Oncol       Date:  2022-05-24       Impact factor: 4.339

4.  Variation in Additional Breast Imaging Orders and Impact on Surgical Wait Times at a Comprehensive Cancer Center.

Authors:  Mehra Golshan; Katya Losk; Melissa A Mallory; Kristen Camuso; Susan Troyan; Nancy U Lin; Sarah Kadish; Craig A Bunnell
Journal:  Ann Surg Oncol       Date:  2015-08-26       Impact factor: 5.344

5.  Implementation of a Breast/Reconstruction Surgery Coordinator to Reduce Preoperative Delays for Patients Undergoing Mastectomy With Immediate Reconstruction.

Authors:  Mehra Golshan; Katya Losk; Melissa A Mallory; Kristen Camuso; Linda Cutone; Stephanie Caterson; Craig A Bunnell
Journal:  J Oncol Pract       Date:  2016-02-16       Impact factor: 3.840

6.  Impact of Second Opinions in Breast Cancer Diagnostics and Treatment: A Retrospective Analysis.

Authors:  E Heeg; Y A Civil; M A Hillen; C H Smorenburg; L A E Woerdeman; E J Groen; H A O Winter-Warnars; M T F D Vrancken Peeters
Journal:  Ann Surg Oncol       Date:  2019-10-11       Impact factor: 5.344

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.